Latest Business and People News
Updated employee announcements, business news and recognition in the industry today.
People
Cliff Echols
SCORR Marketing, a global health science marketing and communications firm, has announced the addition of three employees--Cliff Echols as market intelligence director; and Kerry Hutchings and Cherie Squires as senior directors of program management.
Kerry Hutchings
TFS International, a Sweden-based, global mid-size CRO, has appointed Birgitte Volck, MD, PhD, as a non-executive Director to serve on the Company's Board of Directors. Dr. Volck is the Senior Vice President, Head of R&D Rare Disease at GlaxoSmithKline in the UK. Schulman IRB, a central IRB, announced Michele Russell-Einhorn, JD, will join the organization September 1, 2016, as Vice President for Oncology Services. Russell-Einhorn currently is Senior Director of Dana-Farber Cancer Institute’s Office for Human Research Studies. At Schulman IRB, she will build and lead the company’s forthcoming Central Oncology Review (COR) division, launching later in 2016.
Cherie Squires
Business News Dr Rabinder Buttar, founder and CEO of ClinTec International, joined an industry-leading expert panel of judges for the eighth round final of the Scottish EDGE competition, which identifies and supports Scotland’s up-and-coming, innovative, high-growth generating entrepreneurial talent. Recognition Q2 Solutions, a global clinical trials laboratory services organization and joint venture of Quest and Quintiles, has received the 2016 Lilly Global Supplier Award. Q2 Solutions was one of 12 companies to receive the award this year, recognizing the company’s ongoing contributions to Lilly’s drug development efforts. ClinCapture, a provider of free and validated electronic data capture (EDC) software, announced its nomination for a Bronze 2016 Stevie Award by the American Business Awardsâ in the Cloud Application/Service as well as the Software Development Solution Website category.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
Pfizer Reports Strong Phase III Results for Hympavzi in Hemophilia Patients with Inhibitors
June 26th 2025The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with hemophilia A or B with inhibitors, offering a promising new prophylactic option for a population with limited therapeutic choices.
